ストックスクリーナーアプリを入手
0.6119
0.50%
-0.0031
前日終値:
$0.615
開ける：
$0.615
24時間の取引高:
124.00K
Relative Volume:
0.21
時価総額：
$41.32M
収益：
-
当期純損益:
$-81.22M
株価収益率:
-0.2067
EPS:
-2.96
ネットキャッシュフロー:
$-74.41M
1週間 パフォーマンス:
+2.48%
1か月 パフォーマンス:
-7.55%
6か月 パフォーマンス:
-10.28%
1年 パフォーマンス:
-17.28%
1日の値動き範囲:
$0.6117
$0.6241
1週間の範囲:
$0.5734
$0.6489
52週間の値動き範囲:
$0.5734
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
XLO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.6118 | 41.54M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.38 | 120.31B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
757.42 | 81.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
845.68 | 53.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
351.94 | 46.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
347.98 | 37.20B | 4.98B | 69.59M | 525.67M | 0.5197 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-06 | 開始されました | Leerink Partners | Outperform |
| 2022-12-21 | 開始されました | Chardan Capital Markets | Buy |
| 2022-01-10 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-16 | 開始されました | Cowen | Outperform |
| 2021-11-16 | 開始されました | Guggenheim | Buy |
| 2021-11-16 | 開始されました | Morgan Stanley | Overweight |
| 2021-11-16 | 開始されました | Raymond James | Outperform |
すべてを表示
Xilio Therapeutics Inc (XLO) 最新ニュース
Sell Signal: What is AAMUs market position2025 Dividend Review & High Win Rate Trade Tips - baoquankhu1.vn
Highs Report: What is Espey Mfg Electronics Corps market positionJuly 2025 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn
US Stocks Recap: Whats the fair value of Xilio Therapeutics Inc stockShort Setup & Technical Pattern Alert System - baoquankhu1.vn
Xilio Therapeutics (NASDAQ: XLO) reverse split vote to keep listing - Stock Titan
Performance Recap: Is Xilio Therapeutics Inc in accumulation or distribution phase2025 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Update Recap: Can Xilio Therapeutics Inc sustain earnings growthJuly 2025 Final Week & Weekly Hot Stock Watchlists - baoquankhu1.vn
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates - Sahm
What dividend safety score for Xilio Therapeutics Inc. stockPortfolio Update Report & Technical Pattern Based Signals - Улправда
How Xilio Therapeutics Inc. stock reacts to bond yieldsWeekly Investment Summary & Weekly High Return Forecasts - Улправда
Is Xilio Therapeutics Inc. stock a contrarian buyEarnings Summary Report & Weekly Sector Rotation Insights - Улправда
Xilio Therapeutics secures $35.8 million from warrant exercises By Investing.com - Investing.com India
Xilio Therapeutics, Inc. Announces Change of Chair of the Board of Directors - MarketScreener
Why Xilio Therapeutics Inc. stock attracts high net worth investorsWeekly Trend Summary & Breakout Confirmation Alerts - ulpravda.ru
Xilio Therapeutics extends cash runway into 2027 - MSN
Xilio Therapeutics Inc appoints Sara Bonstein as chair of board - MarketScreener
Xilio Therapeutics Announces Leadership Transition and Pipeline Updates - TipRanks
Xilio Therapeutics Announces Board Leadership Change - TradingView — Track All Markets
Is Xilio Therapeutics Inc. stock supported by strong fundamentalsMarket Risk Analysis & Safe Entry Point Alerts - Улправда
Xilio Therapeutics secures $35.8 million from warrant exercises - Investing.com
Xilio Therapeutics (NASDAQ: XLO) updates cash and appoints new board chair - Stock Titan
Xilio Therapeutics Extends Cash Runway Into 2027 - The Globe and Mail
Xilio shares soar on AbbVie collaboration deal - MSN
Xilio Therapeutics reports $35.8 million in proceeds from Series B warrant exercises By Investing.com - Investing.com South Africa
Xilio Therapeutics reports $35.8 million in proceeds from Series B warrant exercises - Investing.com Nigeria
Xilio Therapeutics Series B and C Warrants Update - TradingView — Track All Markets
Head to Head Review: Xilio Therapeutics (NASDAQ:XLO) and Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Xilio Therapeutics, Inc. (NASDAQ:XLO) Sees Large Decrease in Short Interest - Defense World
Xilio Therapeutics (NASDAQ:XLO) Stock Price Down 0.5% – What’s Next? - Defense World
Xilio Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Will Xilio Therapeutics Inc. stock reach all time highs in 20252025 Market Overview & High Accuracy Swing Trade Signals - bolumsonucanavari.com
Can Xilio Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 PreEarnings & Risk Managed Investment Strategies - Улправда
Is Xilio Therapeutics Inc. stock dividend yield sustainableWeekly Market Report & High Conviction Investment Ideas - Улправда
Is Xilio Therapeutics Inc. stock a defensive play in 2025July 2025 Sector Moves & Free Fast Gain Swing Trade Alerts - Улправда
Loss Report: Can Xilio Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 EndofMonth & High Win Rate Trade Alerts - Улправда
Why Xilio Therapeutics Inc. stock remains undervaluedJuly 2025 Reactions & High Win Rate Trade Tips - bolumsonucanavari.com
Xilio Therapeutics Inc (XLO) looking to reclaim success with recent performance - setenews.com
Xilio Therapeutics Inc (XLO) can make a big difference with a little luck - setenews.com
Xilio Therapeutics, Inc. (XLO) -5.65% in After-hours: Slide Amid Routine Trading Conditions - Stocks Telegraph
Is Xilio Therapeutics Inc. stock trading at a premium valuationJuly 2025 Sentiment & Fast Gain Swing Alerts - Newser
Why Xilio Therapeutics Inc. stock is trending among retail traders2025 Price Action Summary & Expert Curated Trade Ideas - Newser
Can Xilio Therapeutics Stock Recover If Markets Fall? - Trefis
Recap Report: Why Xilio Therapeutics Inc. stock attracts high net worth investorsProduct Launch & High Accuracy Investment Signals - moha.gov.vn
Xilio Therapeutics announces pricing of $50 million public offering - MSN
Xilio Therapeutics Approves 2025 Stock Incentive Plan - MSN
[S-8] Xilio Therapeutics, Inc. Employee Benefit Plan Registration | XLO SEC FilingForm S-8 - Stock Titan
[Form 4] Xilio Therapeutics, Inc. Insider Trading Activity - Stock Titan
[8-K] Xilio Therapeutics, Inc. Reports Material Event | XLO SEC FilingForm 8-K - Stock Titan
Xilio Therapeutics Inc (XLO) 財務データ
収益
当期純利益
現金流量
EPS
1.20%
3.27%
大文字化:
|
ボリューム (24 時間):